Idaho Pharmacy at Center of Ivermectin Controversy: Co-Owner Lawmaker Navigates New Over-the-Counter Sales Legislation Amid Regulatory Confusion

Hayden, Idaho — A pharmacy co-owned by a local lawmaker is one of the few in the state selling ivermectin over the counter, following a new law that allows such sales. The move comes amid ongoing debates regarding the drug’s legality and safety, especially after its heightened visibility during the COVID-19 pandemic. Ivermectin, an anti-parasitic commonly used for both humans and animals, has sparked significant interest since the pandemic began. Despite its popularity as a treatment for COVID-19, the federal Food and Drug Administration (FDA) does not endorse its use for the virus, pointing to … Read more

Revolutionizing Legal Tech: Jylo CEO Unveils Cutting-Edge AI Platform for Seamless Adoption

London, United Kingdom — In a significant step towards transforming legal practices, Jylo, an innovative AI platform, is redefining how legal teams integrate artificial intelligence into their workflows. Shawn Curran, the platform’s CEO and co-founder, leads a comprehensive demonstration that highlights Jylo’s capabilities, aiming to streamline AI adoption for lawyers. Jylo’s core mission is to simplify and optimize the deployment of generative AI across various legal applications. The startup emphasizes user-friendly access to advanced AI models and the development of intelligent workflows. Through its AI Playbook Marketplace, teams can securely access latest technologies while collaboratively … Read more

Federal Judge Compels NIH to Reinstate Diversity Research Grants, Igniting New Conversations on Equity in Science

A federal judge in Washington ordered the National Institutes of Health to reinstate a set of research grants focused on enhancing diversity within the biomedical field. The verdict emerged from a dispute over funding allocations intended for projects that promote inclusivity and broaden participation in health research. The controversy traces back to the NIH’s decision to cut funding for certain grants that aimed to support underrepresented groups in scientific research. Critics of this move argued that the decision undermined efforts to create a more equitable environment in the research community. The NIH had justified its … Read more